Chinese experts develop noninvasive tumor therapy
BEIJING -- Chinese experts developed a noninvasive tumor therapy with high performance and low side effects, according to a report by Science and Technology Daily.
The research published in Advanced Therapeutics was jointly carried out by the Nanjing Medical University and Grahope New Materials (GNM), a company focusing on the research and development of graphene technology.
The study found that a specific far-infrared ray generated from a single-layer graphene-based device can effectively suppresses tumor growth and spread of cancer cells and prolongs survival in tumor-bearing mice.
Compared with the carbon fiber device, the graphene-based device produced by GNM can emit a far-infrared ray with strong penetration, which is the reason why it can speed up the death of cancer cells.
"The innovative research and application of the graphene-based device provide cancer patients with a creative treatment method which enjoys broad clinical prospects," Ren Yahui, former chief physician of Baoding No 1 Hospital of Traditional Chinese Medicine in North China's Hebei province, was quoted by the report as saying.
- Arab League delegation visits China-Arab Research Center on Reform and Development for 10th anniversary
- Shanghai Jiao Tong University launches Center for Studies of Global South Sustainable Development
- Ex-CNNC general manager faces disciplinary probe
- China launches long march 12 rocket, deploys satellites for expanding space network
- Global gathering transforms Yixing village into youth hub
- China's prosecutors intensify crackdown on crime, charge 1.27 million in first 11 months of 2025
































